Literature DB >> 4674353

Improvement of the specificity of an antiserum to -lactamase by absorption with a mutant which does not produce the enzyme.

G W Ross, M G Boulton.   

Abstract

Absorption of antiserum to crude beta-lactamase with a mutant strain lacking the enzyme produced specific beta-lactamase antiserum.

Mesh:

Substances:

Year:  1972        PMID: 4674353      PMCID: PMC251586          DOI: 10.1128/jb.112.3.1435-1437.1972

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  6 in total

1.  PURIFICATION AND PROPERTIES OF THE EXOPENICILLINASE FROM STAPHYLOCOCCUS AUREUS.

Authors:  M H RICHMOND
Journal:  Biochem J       Date:  1963-09       Impact factor: 3.857

2.  An immunological study of the constitutive and the penicillin-induced penicillinases of Bacillus cereus, based on specific enzyme neutralization by antibody.

Authors:  M R POLLOCK
Journal:  J Gen Microbiol       Date:  1956-02

3.  A comparative study of eight distinct beta-lactamases synthesized by gram-negative bacteria.

Authors:  G W Jack; M H Richmond
Journal:  J Gen Microbiol       Date:  1970-04

4.  Effects of beta-lactamase from gram-negative organisms on cephalosporins and penicillins.

Authors:  C H O'Callaghan; P W Muggleton; G W Ross
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968

5.  Comparative immunological studies of two Pseudomonas enzymes.

Authors:  R Y Stanier; D Wachter; C Gasser; A C Wilson
Journal:  J Bacteriol       Date:  1970-05       Impact factor: 3.490

6.  The purification and some properties of a beta-lactamase (cephalosporinase) synthesized by Enterobactercloacae.

Authors:  T D Hennessey; M H Richmond
Journal:  Biochem J       Date:  1968-09       Impact factor: 3.857

  6 in total
  1 in total

1.  Epidemiological study of an outbreak due to multidrug-resistant Enterobacter aerogenes in a medical intensive care unit.

Authors:  C Arpin; C Coze; A M Rogues; J P Gachie; C Bebear; C Quentin
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.